why choose us

First received: August 19, 2022

Clinical Trial: An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Kidney Disease

Study Type: OBSERVATIONAL


Official Title: FINErenone druG Utilization Study and Assessment of Temporal Changes Following Availability of Different Treatment Options in Patients With Chronic Kidney Disease and Type 2 Diabetes

Brief Summary: This is an observational study in which data from people with chronic kidney disease (CKD) and type 2 diabetes (T2D) who have already started or will start CKD or T2D treatment are collected and studied.In observational studies, only observations are made without specified advice or interventions.People receiving the following CKD or T2D treatments as recommended by their doctors will be included:Sodium-glucose cotransporter 2 inhibitors (SGLT2i),Glucagon-like peptide-1 receptor agonists (GLP-1 RA),Steroidal…

Read more